Tapewire

Nasdaq · USD

RLAY

Relay Therapeutics, Inc.

Export transactions ↓
Tapewire entity
4044
SEC CIK
0001812364
Parsed reports
317

Last 12 months

Inside the activity.

0 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202607
Feb 202600
Mar 202601
Apr 202605
May 202601
Jun 202606
Jul 202606
Aug 202604
Sep 202603
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 24, 2022 Filed Mar 29, 2022 00:18 UTC
Catinazzo ThomasChief Financial Officer
Exercise / conversionCommon Stock 13,286 $4.12 $54,738.32
Disclosure

SEC source: 0001209191-22-021390 · doc4.xml · nonDerivative · entry 1

Catinazzo Thomas · CIK 0001818261 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,545

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2021.

F2 · balance_after: Includes 52,165 shares underlying RSUs.

Read SEC document
March 24, 2022 Filed Mar 29, 2022 00:11 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-22-021388 · doc4.xml · derivative · entry 3

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,456

Underlying: Common Stock · 10,000 shares

Expires 2028-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
March 24, 2022 Filed Mar 29, 2022 00:11 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 10,000 $30.00 $300,000.00
Disclosure

SEC source: 0001209191-22-021388 · doc4.xml · nonDerivative · entry 2

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,926

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F2 · balance_after: Includes 93,387 shares underlying restricted stock units.

Read SEC document
March 24, 2022 Filed Mar 29, 2022 00:11 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionCommon Stock 10,000 $4.12 $41,200.00
Disclosure

SEC source: 0001209191-22-021388 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,926

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F2 · balance_after: Includes 93,387 shares underlying restricted stock units.

Read SEC document
March 10, 2022 Filed Mar 12, 2022 00:02 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-22-018291 · doc4.xml · derivative · entry 3

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,456

Underlying: Common Stock · 10,000 shares

Expires 2028-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
March 10, 2022 Filed Mar 12, 2022 00:02 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 10,000 $25.00 $250,000.00
Disclosure

SEC source: 0001209191-22-018291 · doc4.xml · nonDerivative · entry 2

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,926

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F2 · balance_after: Includes 93,387 shares underlying restricted stock units.

Read SEC document
March 10, 2022 Filed Mar 12, 2022 00:02 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionCommon Stock 10,000 $4.12 $41,200.00
Disclosure

SEC source: 0001209191-22-018291 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,926

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F2 · balance_after: Includes 93,387 shares underlying restricted stock units.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:31 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-22-015724 · doc4.xml · derivative · entry 3

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,456

Underlying: Common Stock · 8,000 shares

Expires 2028-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:31 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 8,000 $23.88 $191,040.00
Disclosure

SEC source: 0001209191-22-015724 · doc4.xml · nonDerivative · entry 2

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,926

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F3 · price: This transaction was executed in multiple trades at prices ranging from $22.23 to $24.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 93,387 shares underlying restricted stock units.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 22:31 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionCommon Stock 8,000 $4.12 $32,960.00
Disclosure

SEC source: 0001209191-22-015724 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,926

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F2 · balance_after: Includes 93,387 shares underlying restricted stock units.

Read SEC document
February 22, 2022 Filed Feb 23, 2022 02:01 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 8,000 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-22-011991 · doc4.xml · derivative · entry 5

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245,456

Underlying: Common Stock · 8,000 shares

Expires 2028-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F6 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
February 22, 2022 Filed Feb 23, 2022 02:01 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 2,752 $20.97 $57,709.44
Disclosure

SEC source: 0001209191-22-011991 · doc4.xml · nonDerivative · entry 4

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,926

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F5 · price: This transaction was executed in multiple trades at prices ranging from $20.76 to $21.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 93,387 shares underlying restricted stock units.

Read SEC document
February 22, 2022 Filed Feb 23, 2022 02:01 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 12,242 $20.94 $256,347.48
Disclosure

SEC source: 0001209191-22-011991 · doc4.xml · nonDerivative · entry 3

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,678

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F4 · price: This transaction was executed in multiple trades at prices ranging from $20.26 to $21.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 93,387 shares underlying restricted stock units.

Read SEC document
February 22, 2022 Filed Feb 23, 2022 02:01 UTC
Bergstrom Donald APresident, R&D
SaleCommon Stock 8,000 $20.94 $167,520.00
Disclosure

SEC source: 0001209191-22-011991 · doc4.xml · nonDerivative · entry 2

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,920

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F3 · price: This transaction was executed in multiple trades at prices ranging from $20.27 to $21.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 93,387 shares underlying restricted stock units.

Read SEC document
February 22, 2022 Filed Feb 23, 2022 02:01 UTC
Bergstrom Donald APresident, R&D
Exercise / conversionCommon Stock 8,000 $4.12 $32,960.00
Disclosure

SEC source: 0001209191-22-011991 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 7, 2022.

F2 · balance_after: Includes 93,387 shares underlying restricted stock units.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 22:25 UTC
Patel SanjivDirector · President and CEO
GrantStock Option (Right to Buy) · Derivative 527,140 $0.00 Strike: $20.38 $0.00
Disclosure

SEC source: 0001209191-22-005675 · doc4.xml · derivative · entry 1

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 527,140

Underlying: Common Stock · 527,140 shares

Expires 2032-01-26

F1 · derivative.exercise_date: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 22:21 UTC
Catinazzo ThomasChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 78,540 $0.00 Strike: $20.38 $0.00
Disclosure

SEC source: 0001209191-22-005669 · doc4.xml · derivative · entry 2

Catinazzo Thomas · CIK 0001818261 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,540

Underlying: Common Stock · 78,540 shares

Expires 2032-01-26

F3 · derivative.exercise_date: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 22:21 UTC
Catinazzo ThomasChief Financial Officer
GrantCommon Stock 39,270 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-005669 · doc4.xml · nonDerivative · entry 1

Catinazzo Thomas · CIK 0001818261 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,259

F1 · shares: Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date.

F2 · balance_after: Includes 52,165 shares underlying RSUs.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 22:28 UTC
Porter AndyChief Administrative Officer
GrantStock Option (Right to Buy) · Derivative 48,340 $0.00 Strike: $20.38 $0.00
Disclosure

SEC source: 0001209191-22-005682 · doc4.xml · derivative · entry 2

Porter Andy · CIK 0001899340 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,340

Underlying: Common Stock · 48,340 shares

Expires 2032-01-26

F3 · derivative.exercise_date: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 22:28 UTC
Porter AndyChief Administrative Officer
GrantCommon Stock 24,170 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-005682 · doc4.xml · nonDerivative · entry 1

Porter Andy · CIK 0001899340 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,317

F1 · shares: Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date.

F2 · balance_after: Includes 35,545 shares underlying RSUs.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 22:17 UTC
Bergstrom Donald APresident, R&D
GrantStock Option (Right to Buy) · Derivative 129,900 $0.00 Strike: $20.38 $0.00
Disclosure

SEC source: 0001209191-22-005662 · doc4.xml · derivative · entry 2

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,900

Underlying: Common Stock · 129,900 shares

Expires 2032-01-26

F3 · derivative.exercise_date: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 22:17 UTC
Bergstrom Donald APresident, R&D
GrantCommon Stock 64,950 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-005662 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · President, R&D

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,920

F1 · shares: Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date.

F2 · balance_after: Includes 93,387 shares underlying RSUs.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 22:13 UTC
Adams BrianChief Legal Officer
GrantStock Option (Right to Buy) · Derivative 78,540 $0.00 Strike: $20.38 $0.00
Disclosure

SEC source: 0001209191-22-005645 · doc4.xml · derivative · entry 2

Adams Brian · CIK 0001636994 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,540

Underlying: Common Stock · 78,540 shares

Expires 2032-01-26

F3 · derivative.exercise_date: The shares underlying this stock option shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date.

Read SEC document
January 27, 2022 Filed Jan 31, 2022 22:13 UTC
Adams BrianChief Legal Officer
GrantCommon Stock 39,270 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-005645 · doc4.xml · nonDerivative · entry 1

Adams Brian · CIK 0001636994 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,917

F1 · shares: Represents restricted stock units ("RSUs") granted to the reporting person pursuant to the Issuer's 2020 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting. The RSUs shall vest in sixteen (16) equal quarterly installments commencing on January 27, 2022, subject to the reporting person's continued service with the Issuer through each vesting date.

F2 · balance_after: Includes 52,165 shares underlying RSUs.

Read SEC document
December 31, 2021 Filed Jan 7, 2022 22:13 UTC
Patel SanjivDirector · President and CEO
GrantCommon Stock 658 $26.10 $17,173.80
Disclosure

SEC source: 0001209191-22-002465 · doc4.xml · nonDerivative · entry 1

Patel Sanjiv · CIK 0001816210 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,740

F1 · kind: The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.

F2 · price: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 31, 2021.

Read SEC document
December 31, 2021 Filed Jan 7, 2022 22:15 UTC
Adams BrianGeneral Counsel
GrantCommon Stock 658 $26.10 $17,173.80
Disclosure

SEC source: 0001209191-22-002471 · doc4.xml · nonDerivative · entry 1

Adams Brian · CIK 0001636994 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,647

F1 · kind: The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.

F2 · price: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 31, 2021.

F3 · balance_after: Includes 12,895 shares underlying RSUs.

Read SEC document
December 27, 2021 Filed Dec 28, 2021 00:43 UTC
Catinazzo ThomasSenior Vice President, Finance
SaleCommon Stock 295 $33.10 $9,764.50
Disclosure

SEC source: 0001209191-21-071314 · doc4.xml · nonDerivative · entry 1

Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,989

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on December 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 12,895 shares underlying RSUs.

Read SEC document
December 27, 2021 Filed Dec 28, 2021 00:39 UTC SaleCommon Stock 649 $33.10 $21,481.90
Disclosure

SEC source: 0001209191-21-071312 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,970

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,188 shares of restricted stock units ("RSUs") on December 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 28,437 shares underlying RSUs.

Read SEC document
December 27, 2021 Filed Dec 28, 2021 00:50 UTC
Porter AndySee Remarks
SaleCommon Stock 260 $33.10 $8,606.00
Disclosure

SEC source: 0001209191-21-071318 · doc4.xml · nonDerivative · entry 1

Porter Andy · CIK 0001899340 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,147

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 875 shares of restricted stock units ("RSUs") on December 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 11,375 shares underlying RSUs.

Read SEC document
December 27, 2021 Filed Dec 28, 2021 00:31 UTC
Adams BrianGeneral Counsel
SaleCommon Stock 295 $33.10 $9,764.50
Disclosure

SEC source: 0001209191-21-071308 · doc4.xml · nonDerivative · entry 1

Adams Brian · CIK 0001636994 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,989

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on December 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 12,895 shares underlying RSUs.

Read SEC document
November 15, 2021 Filed Nov 17, 2021 00:14 UTC
Catinazzo ThomasSenior Vice President, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-21-064892 · doc4.xml · derivative · entry 3

Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,543

Underlying: Common Stock · 22,500 shares

Expires 2028-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020.

F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 9, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
November 15, 2021 Filed Nov 17, 2021 00:14 UTC
Catinazzo ThomasSenior Vice President, Finance
SaleCommon Stock 22,500 $35.40 $796,500.00
Disclosure

SEC source: 0001209191-21-064892 · doc4.xml · nonDerivative · entry 2

Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,284

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020.

F3 · price: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 13,887 shares underlying RSUs.

Read SEC document
November 15, 2021 Filed Nov 17, 2021 00:14 UTC
Catinazzo ThomasSenior Vice President, Finance
Exercise / conversionCommon Stock 22,500 $4.12 $92,700.00
Disclosure

SEC source: 0001209191-21-064892 · doc4.xml · nonDerivative · entry 1

Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,784

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020.

F2 · balance_after: Includes 13,887 shares underlying RSUs.

Read SEC document
November 15, 2021 Filed Nov 17, 2021 00:07 UTC
Adams BrianGeneral Counsel
Exercise / conversionStock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-21-064872 · doc4.xml · derivative · entry 3

Adams Brian · CIK 0001636994 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,786

Underlying: Common Stock · 6,500 shares

Expires 2028-03-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020.

F4 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
November 15, 2021 Filed Nov 17, 2021 00:07 UTC
Adams BrianGeneral Counsel
SaleCommon Stock 6,500 $35.42 $230,230.00
Disclosure

SEC source: 0001209191-21-064872 · doc4.xml · nonDerivative · entry 2

Adams Brian · CIK 0001636994 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,284

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020.

F3 · price: This transaction was executed in multiple trades at prices ranging from $35.03 to $35.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · balance_after: Includes 13,887 shares underlying RSUs.

Read SEC document
November 15, 2021 Filed Nov 17, 2021 00:07 UTC
Adams BrianGeneral Counsel
Exercise / conversionCommon Stock 6,500 $4.12 $26,780.00
Disclosure

SEC source: 0001209191-21-064872 · doc4.xml · nonDerivative · entry 1

Adams Brian · CIK 0001636994 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,784

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020.

F2 · balance_after: Includes 13,887 shares underlying RSUs.

Read SEC document
October 15, 2021 Filed Oct 20, 2021 00:56 UTC SaleCommon Stock 30,000 $34.15 $1,024,500.00
Disclosure

SEC source: 0001209191-21-061088 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,619

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $33.309 to $36.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 27, 2021 Filed Sep 28, 2021 01:33 UTC
Catinazzo ThomasSenior Vice President, Finance
SaleCommon Stock 293 $36.87 $10,802.91
Disclosure

SEC source: 0001209191-21-057862 · doc4.xml · nonDerivative · entry 1

Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,284

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on September 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 13,887 shares underlying RSUs.

Read SEC document
September 27, 2021 Filed Sep 28, 2021 01:27 UTC SaleCommon Stock 646 $36.87 $23,818.02
Disclosure

SEC source: 0001209191-21-057860 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,619

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,187 shares of restricted stock units ("RSUs") on September 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 30,625 shares underlying RSUs.

Read SEC document
September 27, 2021 Filed Sep 28, 2021 01:21 UTC
Adams BrianGeneral Counsel
SaleCommon Stock 293 $36.87 $10,802.91
Disclosure

SEC source: 0001209191-21-057858 · doc4.xml · nonDerivative · entry 1

Adams Brian · CIK 0001636994 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,284

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on September 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 13,887 shares underlying RSUs.

Read SEC document
September 13, 2021 Filed Sep 14, 2021 00:24 UTC
Catinazzo ThomasSenior Vice President, Finance
Exercise / conversionStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-21-055783 · doc4.xml · derivative · entry 3

Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,043

Underlying: Common Stock · 22,500 shares

Expires 2028-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020.

F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 9, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
September 13, 2021 Filed Sep 14, 2021 00:24 UTC
Catinazzo ThomasSenior Vice President, Finance
SaleCommon Stock 22,500 $35.00 $787,500.00
Disclosure

SEC source: 0001209191-21-055783 · doc4.xml · nonDerivative · entry 2

Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,577

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020.

Read SEC document
September 13, 2021 Filed Sep 14, 2021 00:24 UTC
Catinazzo ThomasSenior Vice President, Finance
Exercise / conversionCommon Stock 22,500 $4.12 $92,700.00
Disclosure

SEC source: 0001209191-21-055783 · doc4.xml · nonDerivative · entry 1

Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,077

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2020.

Read SEC document
September 13, 2021 Filed Sep 14, 2021 00:27 UTC
Adams BrianGeneral Counsel
Exercise / conversionStock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-21-055784 · doc4.xml · derivative · entry 3

Adams Brian · CIK 0001636994 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,286

Underlying: Common Stock · 6,500 shares

Expires 2028-03-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020.

F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on March 19, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document
September 13, 2021 Filed Sep 14, 2021 00:27 UTC
Adams BrianGeneral Counsel
SaleCommon Stock 6,500 $35.02 $227,630.00
Disclosure

SEC source: 0001209191-21-055784 · doc4.xml · nonDerivative · entry 2

Adams Brian · CIK 0001636994 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,577

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 13, 2021 Filed Sep 14, 2021 00:27 UTC
Adams BrianGeneral Counsel
Exercise / conversionCommon Stock 6,500 $4.12 $26,780.00
Disclosure

SEC source: 0001209191-21-055784 · doc4.xml · nonDerivative · entry 1

Adams Brian · CIK 0001636994 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,077

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2020.

Read SEC document
June 28, 2021 Filed Jun 30, 2021 22:26 UTC
Catinazzo ThomasSenior Vice President, Finance
SaleCommon Stock 293 $35.81 $10,492.33
Disclosure

SEC source: 0001209191-21-044063 · doc4.xml · nonDerivative · entry 1

Catinazzo Thomas · CIK 0001818261 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,577

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 991 shares of restricted stock units ("RSUs") on June 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 14,879 shares underlying RSUs.

Read SEC document
June 28, 2021 Filed Jun 30, 2021 22:28 UTC
Adams BrianGeneral Counsel
SaleCommon Stock 293 $35.81 $10,492.33
Disclosure

SEC source: 0001209191-21-044065 · doc4.xml · nonDerivative · entry 1

Adams Brian · CIK 0001636994 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,577

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 991 shares of restricted stock units ("RSUs") on June 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 14,879 shares underlying RSUs.

Read SEC document
June 28, 2021 Filed Jun 30, 2021 22:25 UTC SaleCommon Stock 976 $35.81 $34,950.56
Disclosure

SEC source: 0001209191-21-044062 · doc4.xml · nonDerivative · entry 1

Bergstrom Donald A · CIK 0001709772 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,265

F1 · shares: Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,187 shares of restricted stock units ("RSUs") on June 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.

F2 · balance_after: Includes 32,812 shares underlying RSUs.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 23:38 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 42,242 $0.00 Strike: $4.12 $0.00
Disclosure

SEC source: 0001209191-21-041732 · doc4.xml · derivative · entry 3

Bergstrom Donald A · CIK 0001709772 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,456

Underlying: Common Stock · 42,242 shares

Expires 2028-04-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020.

F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option vested on April 2, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.